| 918 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Influenza Activity - United States, September 29,2013-February 8, 2014 |
Carmen S. Arriola, DVM, PhD1,2, Lynnette Brammer, MPH2, Scott Epperson, MPH2, Lenee Blanton, MPH2, Krista Kniss, MPH2, Desiree Mustaquim, MPH2, Craig Steffens, MPH2, Rosaline Dhara, MPH2, Michelle Leon, MPH2, Alejandro Perez, MPH2, Sandra S. Chaves, MD2, Jackie Katz, PhD2, Teresa Wallis, MS2, Julie Villanueva, PhD2, Xiyan Xu, MD2, Anwar Isa Abd Elal2, Larisa Gubareva, PhD2, Nancy Cox, PhD2, Lyn Finelli, DrPH2, Joseph Bresee, MD2, Michael Jhung MD2 (Author affiliations at end of text). |
| influenza | 0.931576 |
| influenza diagnostic test | 0.533745 |
| influenza hospitalization surveillance | 0.743241 |
| CDC influenza surveillance | 0.551463 |
| United States | 0.644634 |
| novel influenza | 0.533669 |
| quadrivalent influenza vaccine | 0.561233 |
| influenza A viruses | 0.566682 |
| clinician-ordered influenza testing | 0.53382 |
| Surveillance Network | 0.513343 |
| influenza B component | 0.55479 |
| previous influenza seasons | 0.621498 |
| high influenza activity | 0.552577 |
| influenza antiviral medications | 0.539854 |
| influenza B viruses | 0.614142 |
| U.S. Virgin Islands | 0.505572 |
| Cities Mortality Reporting | 0.621984 |
| laboratory-confirmed influenza | 0.603351 |
| influenza A virus | 0.577226 |
| laboratory-confirmed influenza case | 0.537592 |
| Influenza surveillance reports | 0.54984 |
| influenza vaccine | 0.584911 |
| New York | 0.514743 |
|
| influenza season | 0.658859 |
| influenza activity | 0.675833 |
| influenza A subtype | 0.536049 |
| quadrivalent influenza vaccines | 0.561327 |
| U.S. influenza activity* | 0.568663 |
| Hospitalization Surveillance Network | 0.50885 |
| Elevated influenza activity | 0.552015 |
| Enteric Virus Surveillance | 0.511523 |
| influenza complications | 0.547852 |
| Sporadic influenza activity | 0.557685 |
| influenza seasons | 0.625638 |
| influenza virus circulation | 0.582027 |
| ILI activity | 0.543747 |
| persons | 0.512027 |
| influenza viruses | 0.668174 |
| laboratory-confirmed influenza-associated hospitalizations | 0.518836 |
| influenza B virus | 0.565936 |
| influenza deaths | 0.540406 |
| predominant influenza virus | 0.549413 |
| influenza-associated hospitalizations | 0.551271 |
| 2013-14 influenza season | 0.582432 |
| additional Influenza Hospitalization | 0.565297 |
| laboratory-confirmed influenza hospitalizations | 0.554768 |
|
CLICK HERE |
| 1081 |
Centers for Disease Control and Prevention |
Html |
en |
Tribal Motor Vehicle Injury Prevention Programs for Reducing Disparities in Motor Vehicle-Related Injuries |
Bethany A. West, MPH. |
| sobriety checkpoints | 0.611096 |
| White Mountain Apache | 0.54479 |
| Carlos Apache Tribe | 0.494468 |
| Alternate Text | 0.4852 |
| Tohono O'odham Nation | 0.477695 |
| alcohol-impaired driving enforcement | 0.480226 |
| safety seat distribution | 0.514203 |
| driver seat belt | 0.503237 |
| police officers | 0.485154 |
| rear-facing child safety | 0.496096 |
| Tribal police data | 0.481997 |
| alcohol-impaired driving | 0.652159 |
| SCAT | 0.47498 |
| motor vehicle safety | 0.493294 |
| booster seat installation | 0.487788 |
| police enforcement | 0.489414 |
| seat belt violation | 0.499657 |
| motor vehicle–related injuries | 0.625137 |
| safety seat education | 0.518659 |
| San Carlos Apache | 0.568875 |
| Mountain Apache Tribe | 0.50525 |
| alcohol-impaired driving laws | 0.484807 |
| comprehensive media campaign | 0.498197 |
| programs | 0.487405 |
| evidence-based road safety | 0.552741 |
|
| seat belt road | 0.508886 |
| seat belts | 0.706299 |
| child safety seats | 0.540974 |
| observational surveys | 0.505515 |
| United States | 0.503848 |
| primary seat belt | 0.535152 |
| child safety | 0.885948 |
| motor vehicle–related injury | 0.481347 |
| seat use laws | 0.482815 |
| Ho-Chunk Nation | 0.482683 |
| child safety seat | 0.798013 |
| seat belt nonuse | 0.593567 |
| injury prevention | 0.49282 |
| American Indians/Alaska Natives | 0.615905 |
| child passenger safety | 0.52101 |
| Indian Health Service | 0.504082 |
| tribal environmental health | 0.480124 |
| seat belt | 0.903563 |
| enforcement seat belt | 0.52554 |
| American Indian/Alaska Native | 0.653476 |
| Community Preventive Services | 0.508506 |
| motor vehicle crashes | 0.568625 |
| Service Seat Belt | 0.508312 |
| road safety interventions | 0.563015 |
|
CLICK HERE |
| 4674 |
Centers for Disease Control and Prevention |
Html |
en |
Fragile X Syndrome and Associated Disorders | CDC Features |
July 22 is Fragile X Syndrome (FXS) Awareness Day. FXS is the most common known cause of inherited intellectual disability. How much do you know about FXS? Take our quiz to find out. |
| FXS research projects | 0.852687 |
| North Carolina | 0.491698 |
| parent | 0.432937 |
| Fragile X Clinical | 0.530415 |
| families questions | 0.49791 |
| educational programs | 0.493089 |
| fragile X clinics | 0.527365 |
| Research Triangle Institute | 0.568505 |
| large enough group | 0.494407 |
| daily functional skills | 0.572302 |
| Research Consortium | 0.499253 |
| individuals | 0.479106 |
| centralized database | 0.496403 |
| Disease Control | 0.500584 |
| children | 0.436681 |
| state health departments | 0.578697 |
| options | 0.417392 |
| health care providers | 0.585146 |
| social support | 0.493511 |
| helpful advice | 0.502678 |
| research partners | 0.496972 |
| medical services | 0.494195 |
| adulthood | 0.420059 |
| university researchers | 0.498756 |
| intellectual disability | 0.513398 |
|
| parents | 0.451458 |
| child | 0.433985 |
| FXS | 0.968153 |
| United States | 0.498013 |
| intellectual challenges | 0.489615 |
| advancements | 0.420448 |
| national survey | 0.49258 |
| community resources | 0.50474 |
| KB | 0.417983 |
| therapy services | 0.493006 |
| survey results | 0.494846 |
| health care | 0.587877 |
| quiz | 0.420531 |
| good resources | 0.50207 |
| special needs | 0.504341 |
| CDC scientists | 0.516688 |
| complex condition | 0.502376 |
| confidence | 0.417312 |
| Chapel Hill | 0.491629 |
| better treatments | 0.492019 |
| Fragile X Registry | 0.535813 |
| Fragile X Family | 0.520768 |
| information | 0.465356 |
| National Fragile | 0.608404 |
|
CLICK HERE |
| 4944 |
Centers for Disease Control and Prevention |
Html |
en |
Anaplasmosis |
Anaplasmosis is a tickborne disease caused by the bacterium Anaplasma phagocytophilum. It was previously known as human granulocytic ehrlichiosis (HGE) and has more recently been called human granulocytic anaplasmosis (HGA).
|
| Big Disease | 0.503455 |
| human granulocytic ehrlichiosis | 0.707683 |
| United States | 0.500629 |
| MMWR Recommendations | 0.499824 |
| adults | 0.417304 |
| Patient Diagnosis | 0.505386 |
| Tickborne Illnesses | 0.648396 |
| line treatment | 0.508583 |
| COCA call—Little Bite | 0.617838 |
| larvae | 0.423046 |
| Ixodes pacificus | 0.571242 |
| Free CE | 0.594859 |
| distinct phases | 0.523021 |
| Typical symptoms | 0.516066 |
| doxycycline | 0.435105 |
| tick life-cycle | 0.615222 |
| adult ticks | 0.522553 |
| Guidelines | 0.416836 |
| Mountain Spotted Fever | 0.624528 |
| chills | 0.432471 |
| children | 0.417287 |
|
| muscle aches | 0.533466 |
| Tickborne Rickettsial Diseases | 0.88925 |
| tickborne diseases | 0.66417 |
| Ehrlichioses | 0.432777 |
| tick bites | 0.613135 |
| HGA | 0.440853 |
| Borrelia miyamotoi | 0.611372 |
| western black-legged tick | 0.750633 |
| Medscape Expert Commentary | 0.60404 |
| HGE | 0.443741 |
| laboratory tests | 0.50961 |
| Management | 0.428678 |
| tickborne disease | 0.704624 |
| bacterium Anaplasma phagocytophilum | 0.643662 |
| Spotted Fever Group | 0.62396 |
| clinical presentation | 0.510199 |
| human granulocytic anaplasmosis | 0.952561 |
| tick bite | 0.623201 |
| ages | 0.417261 |
| headache | 0.422903 |
| nymph | 0.433673 |
|
CLICK HERE |
| 7066 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Mauritania |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 10063 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Dermal Diseases : r2p |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| dissemination efforts | 0.336741 |
| NIOSH-funded research findings | 0.671836 |
| occupational health-related areas | 0.569958 |
| systemic impacts | 0.330908 |
| worker health | 0.309948 |
| United States | 0.292597 |
| NIOSH initiative | 0.711248 |
| research findings | 0.917938 |
|
| highly effective prevention | 0.592901 |
| workplace solutions | 0.436976 |
| dermal skin notation | 0.594119 |
| NIOSH Pocket Guide | 0.898593 |
| effective products | 0.292106 |
| various industries | 0.293398 |
| effective NIOSH | 0.673331 |
|
CLICK HERE |
| 10083 |
Centers for Disease Control and Prevention |
Html |
en |
Impact for Newborn Screening for CCHD | NCBDDD |
About 30% of newborns with a critical congenital heart defect (CCHD) were diagnosed more than three days after birth. This estimate varied based on the type of heart defect, ranging from about 8% for newborns with pulmonary atresia to 62% for those with coarctation of the aorta. |
| late diagnosis | 0.630589 |
| common type | 0.3609 |
| newborn screening programs | 0.467255 |
| CDC | 0.447421 |
| journal club | 0.367006 |
| American Academy | 0.362611 |
| United States | 0.416109 |
| critical chd | 0.640625 |
| congenital heart | 0.985868 |
| babies | 0.522316 |
| critical CHD need | 0.455179 |
| late detection | 0.421717 |
| National Birth Defects | 0.672876 |
| early death | 0.359655 |
| critical congenital heart | 0.957433 |
| congenital heart disease | 0.552786 |
| JAMA Pediatrics. | 0.359788 |
| CDC funds | 0.385415 |
| heart problems | 0.378611 |
| lowest rate | 0.359205 |
| Critical CHD screening | 0.506 |
| Congenital Heart Public | 0.463375 |
| CCHD screening activities | 0.520714 |
| new study | 0.379336 |
|
| JAMA Pediatrics | 0.436755 |
| Low levels | 0.359265 |
| screening help babies | 0.511373 |
| CDC researchers | 0.407136 |
| study period | 0.36843 |
| birth defects | 0.896561 |
| heart defect | 0.883127 |
| Birth Defects Prevention | 0.669184 |
| congenital heart defect | 0.710219 |
| Defects Prevention Study | 0.667394 |
| study site | 0.423909 |
| simple bedside test | 0.409363 |
| universal screening | 0.407787 |
| heart defect diagnosis | 0.465442 |
| pulmonary atresia | 0.433667 |
| Atlanta Congenital Defects | 0.51912 |
| baby | 0.394501 |
| population-based state tracking | 0.401083 |
| large study | 0.363751 |
| State birth | 0.371502 |
| medical records | 0.48299 |
| newborn screening | 0.698173 |
| congenital heart defects | 0.769819 |
|
CLICK HERE |
| 10508 |
Centers for Disease Control and Prevention |
Html |
en |
Clinical Reminder: Apr 20, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| Medical Device Reporting | 0.377155 |
| Invasive biopsy procedures | 0.396537 |
| ultrasound gel products | 0.52469 |
| inflammatory dermatitis | 0.345605 |
| FDA Safety Information | 0.386992 |
| mucosal contact | 0.346941 |
| transesophageal ultrasound probes* | 0.484388 |
| female genital tract—if | 0.383166 |
| Pharmaceutical Innovations | 0.434088 |
| Gel lot numbers | 0.435182 |
| intact skin | 0.345264 |
| Prompt reporting | 0.343618 |
| FDA identify | 0.352324 |
| transrectal ultrasound procedures | 0.455804 |
| lower airway | 0.352082 |
| digestive tract | 0.343269 |
| Klebsiella oxytoca bacteria | 0.447991 |
| safety communication | 0.388206 |
| bloodstream infections | 0.344843 |
| original container | 0.343587 |
| hospital/facility policies | 0.343097 |
| transvaginal ultrasound procedures | 0.455429 |
| ultrasound gel | 0.689716 |
| infection | 0.372666 |
|
| ultrasound transducers | 0.413365 |
| unopened bottles | 0.343906 |
| Klebsiella bacteria | 0.423263 |
| Generic Ultrasound Transmission | 0.920641 |
| Klebsiella oxytoca | 0.470488 |
| user facility | 0.341933 |
| upper airway | 0.394808 |
| ultrasound gel product | 0.524763 |
| possible added bioburden | 0.379205 |
| Pseudomonas aeruginosa | 0.757664 |
| reporting hospital | 0.344409 |
| Ultrasound Transmission Gel | 0.967484 |
| sterile ultrasound gel | 0.606521 |
| reporting procedures | 0.349327 |
| non-sterile ultrasound gel | 0.533471 |
| bacteria Pseudomonas aeruginosa | 0.590724 |
| lower GI tract | 0.380154 |
| adverse events | 0.375731 |
| Review clinical policies | 0.377442 |
| wound infection | 0.357938 |
| Adverse Event Reporting | 0.380295 |
| Pharmaceutical Innovations Inc. | 0.377653 |
| transesophageal echocardiography | 0.351796 |
| Other-Sonic Generic Ultrasound | 0.908737 |
|
CLICK HERE |
| 13743 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: National Bullying Prevention Awareness Month -October 1-31, 2015 |
Bullying is "any unwanted aggressive behavior(s) by another youth or group of youths who are not siblings or current dating partners that involves an observed or perceived power imbalance and is repeated multiple times or is highly likely to be repeated" (1). As a form of youth violence, bullying can include aggression that is physical (e.g. |
| multiple times | 0.646716 |
| academic problems | 0.631043 |
| Conflict Peace Res | 0.724444 |
| United States | 0.639085 |
| U.S. Government Printing | 0.730774 |
| original MMWR paper | 0.723446 |
| Human Services | 0.712799 |
| Bullying Prevention Awareness | 0.990451 |
| poor school adjustment | 0.757935 |
| Baldry A. Individual | 0.740498 |
| schoolwide anti-bullying policies | 0.757468 |
| MMWR HTML versions | 0.727424 |
| U.S. Department | 0.710599 |
| MMWR readers | 0.629924 |
| rumor spreading | 0.645213 |
| youth violence | 0.645845 |
| electronic PDF version | 0.718701 |
| school rules | 0.64583 |
| following elements | 0.620545 |
| multisectoral partners | 0.630188 |
| school property | 0.654005 |
| unwanted aggressive behavior | 0.766106 |
| instant messaging | 0.633737 |
|
| school staff | 0.644842 |
| different professionals | 0.625854 |
| school-based bullying prevention | 0.984812 |
| Electronic aggression | 0.662534 |
| text messaging | 0.641384 |
| behavior management techniques | 0.733808 |
| risk factors | 0.622057 |
| school bullying | 0.876474 |
| Additional information | 0.626331 |
| Contact GPO | 0.645059 |
| sleep difficulties | 0.624535 |
| typeset documents | 0.623826 |
| trade names | 0.622454 |
| commercial sources | 0.622375 |
| ultimate goal | 0.634871 |
| mobile telephone technology | 0.764977 |
| current prices | 0.623805 |
| U.S. high school | 0.776813 |
| non-CDC sites | 0.622088 |
| original paper copy | 0.720978 |
| power imbalance | 0.65402 |
| chat room | 0.643158 |
|
CLICK HERE |
| 16087 |
Centers for Disease Control and Prevention |
Html |
en |
Newsletters | NHSN |
CDC’s National Healthcare Safety Network is the nation’s most widely used healthcare-associated infection tracking system. |
| NHSN Releases Version | 0.397234 |
| Quality Reporting Program | 0.441277 |
| NHSN Announces New | 0.42731 |
| hai surveillance changes | 0.425379 |
| NHSN Patient Safety | 0.42633 |
| Infection Control | 0.500348 |
| new nhsn | 0.568289 |
| Safety Protocol release | 0.432887 |
| cms quality reporting | 0.557455 |
| NHSN Member Meetings | 0.454716 |
| new NHSN LabID | 0.451887 |
| new NHSN reporting | 0.50062 |
| electronic reporting | 0.38972 |
| NHSN presentations | 0.398578 |
| NHSN topics | 0.529038 |
| issue | 0.561853 |
| NHSN Antimicrobial | 0.382715 |
| protocol updates | 0.494119 |
| new NHSN manuals | 0.457617 |
| NHSN Contact Information | 0.43118 |
| NHSN analysis modification | 0.438902 |
| general NHSN updates | 0.66231 |
| NHSN Demo application | 0.418591 |
| NHSN pathogen code | 0.432414 |
| Annual Conference | 0.492496 |
|
| NHSN Newsletter | 0.961553 |
| upcoming NHSN Beta | 0.452391 |
| cms quality | 0.583631 |
| NHSN Re-baseline work | 0.521769 |
| NHSN Application Updates | 0.456177 |
| nhsn analysis | 0.443385 |
| new NHSN training | 0.518034 |
| NHSN Annual Training | 0.473892 |
| NHSN Member Meeting | 0.423319 |
| Patient Safety Protocol | 0.5184 |
| CMS reporting requirements | 0.416208 |
| PDF | 0.627726 |
| protocol changes | 0.446966 |
| NHSN Helpdesk Tips | 0.409573 |
| NHSN HAI surveillance | 0.448021 |
| NHSN Helpdesk | 0.412477 |
| NHSN Rebaseline | 0.387539 |
| new NHSN website | 0.460541 |
| NHSN Special Edition | 0.409464 |
| Hospital IQR Program | 0.383088 |
| NHSN Members Meeting | 0.836524 |
| NHSN Organism List | 0.445839 |
| NHSN changes | 0.389388 |
| New NHSN Facility | 0.445608 |
|
CLICK HERE |